Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 7, 2005; 11(1): 27-30
Published online Jan 7, 2005. doi: 10.3748/wjg.v11.i1.27
Table 1 Incidence of EBER-1 expression in gastric carcinoma by histological type.
Histological typeMale Positive/tested (%)Female Positive/tested (%)Total Positive/tested (%)
Intestinal1/30 (3.3)0/18 (0)1/48 (2.1)
Tub10/7 (0)0/11 (0)0/18 (0)
Tub21/23 (4.3)0/7 (0)1/30 (3.3)
Diffuse11/56 (19.6)2/35 (5.7)13/91 (14.2)
Por17/16 (43.7)2/13 (15.3)9/29 (31.0)
Por24/22 (18.1)0/6 (0)4/28 (14.2)
Sig0/15 (0)0/12 (0)0/27 (0)
Muc0/3 (0)0/4 (0)0/7 (0)
Table 2 Clinicopathological characteristics of EBV incidence in gastric cancer patients.
Intestinal type Positive/tested (%)Diffuse type Positive/tested (%)Total Positive/tested (%)
Age (yr)
20-391/2 (50.0)2/15 (13.3)3/17 (17.6)
40-591/20 (5.0)5/45 (11.1)6/65 (9.2)
≥600/26 (0)5/31 (16.1)5/57 (8.7)
Race
Asian0/16 (0)5/40 (12.5)5/56 (8.9)
Caucasian1/32 (3.1)8/51 (15.6)9/83 (10.8)
Sex
Male1/30 (3.3)11/56 (19.6)12/86 (13.9)
Female0/18 (0)2/35 (5.7)2/53 (3.7)
Location
Upper1/15 (6.6)5/33 (15.1)6/48 (12.5)
Lower0/19 (0)8/40 (20.0)8/59 (13.5)
Unknown0/14 (0)0/18 (0)0/32 (0)